Dapagliflozin reduced the combined risk of worsening heart failure

Cardiology

Dapagliflozin reduced the combined risk of worsening heart failure or cardiovascular death among patients with heart failure and a mildly reduced or preserved ejection fraction.

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction | NEJM
Original Article from The New England Journal of Medicine — Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Leave a Comment

Your email address will not be published. Required fields are marked *

Read More with More InformationMCQs & Info-Bits

Enter the Forum

Forum

No thanks, I’m not interested!

Scroll to Top
Enable Notifications OK No thanks